Androgenic alopecia

  • C. Piérard-Franchimont
  • G. E. Piérard
Chapter

Abstract

Androgenic alopecia is at least in part hereditary. It depends on the androgen impact on hairs at specific sites of the scalp. The result is a progressive shortening of the hair cycle with miniaturization of the hair follicle. It represents a physiological process in men. In women the same is true although it may be secondary to hormonal imbalance.

Keywords

Testosterone Progesterone Androgen Prolactin Dermatitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further reading

  1. Amichai B, Grunwald MH, Sobel R. 50.-reductase inhibitors—a new hope in dermatology? Int JDermatol 1997; 36: 182–4.CrossRefGoogle Scholar
  2. Barth JH. Should men still go bald gracefully? Lancet 2000; 355: 161–2.PubMedCrossRefGoogle Scholar
  3. Greenberg JH, Katz M. Treatment of androgenetic alopecia with a 7.5% herbal preparation. J Dermatol Treat 1996; 7: 159–62.CrossRefGoogle Scholar
  4. Guarrera M, Rebora A. Anagen hairs may fail to replace telogen hairs in early androgenetic female alopecia. Dermatology 1996; 192: 28–31.PubMedCrossRefGoogle Scholar
  5. Kaufman KD, Olsen EA, Whiting D et al Finasteride in the treatment of men with androgenetic alopecia. JAm Acad Dermatol 1998; 39: 578–89.CrossRefGoogle Scholar
  6. Leyden J, Dunlap F, Miller B et al Finasteride in the treatment of man with frontal male pattern hair loss. JAm Acad Dermatol 1999; 40: 930–7.CrossRefGoogle Scholar
  7. Mahé YF, Buan B, Bernard BA. A minoxidil-related compound lacking a C6 substitution still exhibit strong anti-lysyl hydroxylase activity in vitro. Skin Pharmacol 1996; 9: 177–83.PubMedCrossRefGoogle Scholar
  8. Mahé YF, Michelet JF, Billoni N et al Androgenetic alopecia and microinflammation. Int J Dermatol 2000; 39: 576–84.PubMedCrossRefGoogle Scholar
  9. Mazzarella F, Loconsole F, Commisa A, Mastrolonardo M, Vena GA. Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after 16 month therapy course. JDermatol Treat 1997; 8: 189–92.CrossRefGoogle Scholar
  10. Niiyama S, Kojima K, Hamada T, Happle R, Hoffmann R. The novel drug CS891 inhibits 5n-reductase activity in freshly isolated dermal papilla of human hair follicles. Eur J Dermatol 2000; 10: 593–5.PubMedGoogle Scholar
  11. Piérard GE, Piérard-Franchimont C, NikkelsTassoudji N, Nikkels AF, Saint Léger D. Improvement in the inflammatory aspect of androgenetic alopecia. A pilot study with an antimicrobial lotion. J Dermatol Treat 1996; 7: 153–7.CrossRefGoogle Scholar
  12. Piérard-Franchimont C, De Doncker P, Wallace R, Cauwenbergh G, Piérard GE. Ketoconazole shampoo: effect of long term use in male pattern alopecia. Dermatology 1998; 196: 474–7.PubMedCrossRefGoogle Scholar
  13. Price VH. Treatment of hair loss. N Engl JMed 1999; 341: 964–73.CrossRefGoogle Scholar
  14. Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androge-netic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. JAm Acad Dermatol 1999; 41: 717–21.CrossRefGoogle Scholar
  15. Price V, Roberts JL, Hordinsky M et al Lack of efficacy of finasteride in post menopausal women with androgenetic alopecia. J Am Acad Dermatol 2000; 43: 768–76.PubMedCrossRefGoogle Scholar
  16. Rongioletti F, Guarrera M, Rebora A. Physiopathologie de l’alopécie androgénétique Ann Dermatol Venereol 1998; 125: 33–7 Google Scholar
  17. Sasson M, Shupack JL, Stiller MJ. Status of medical treatment for androgenetic alopecia Int J Dermatol 1993; 32: 701–6 Google Scholar
  18. Sawaya ME, Price VH. Different levels of 5n-reductase type I and II, aromatase and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997; 109: 296–300.PubMedCrossRefGoogle Scholar
  19. Shaw JC. Spironolactone in dermatologic therapy JAm Acad Dermatol 1991; 24: 236–43 Google Scholar
  20. Sufki H, Stoudemayer T, Kligman AM, Murphy GF. Quantitative and ultrastructural analysis at inflammatory infiltrates in male pattern alopecia. Acta Derm Venereal 1999; 79: 347–50.CrossRefGoogle Scholar
  21. Unger WP. What’s new in hair replacement sur- gery? Dermatol Clin 1996; 14 (4): 783–802.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • C. Piérard-Franchimont
  • G. E. Piérard

There are no affiliations available

Personalised recommendations